Compare UAA & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UAA | ITGR |
|---|---|---|
| Founded | 1996 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.7B |
| IPO Year | N/A | 2000 |
| Metric | UAA | ITGR |
|---|---|---|
| Price | $5.77 | $85.70 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 16 | 8 |
| Target Price | $6.18 | ★ $95.00 |
| AVG Volume (30 Days) | ★ 15.3M | 619.1K |
| Earning Date | 02-06-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.42 |
| Revenue | ★ $5,049,070,000.00 | $1,831,074,000.00 |
| Revenue This Year | N/A | $9.58 |
| Revenue Next Year | $1.46 | N/A |
| P/E Ratio | ★ N/A | $35.26 |
| Revenue Growth | N/A | ★ 9.54 |
| 52 Week Low | $4.13 | $62.00 |
| 52 Week High | $8.72 | $146.36 |
| Indicator | UAA | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 68.93 | 71.85 |
| Support Level | $5.39 | $81.89 |
| Resistance Level | $5.81 | $85.23 |
| Average True Range (ATR) | 0.29 | 2.10 |
| MACD | 0.04 | 0.49 |
| Stochastic Oscillator | 79.59 | 96.47 |
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and Latin America. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through wholesale partners, company-owned digital channels, and approximately 450 company-owned outlet and full-price stores. The Baltimore-based firm was founded in 1996 and is led by controlling shareholder Kevin Plank.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.